Significant Interaction Between a Chemotherapy Benefit and Menopausal Status Found in Terms of Invasive Disease–Free Survival

In a prespecified RxPONDER analysis, postmenopausal women with 1 to 3 positive axillary lymph nodes and a recurrence score of 0 to 25 were able to safely forgo adjuvant chemotherapy for breast cancer